Eli Lilly to present data from studies of orforglipron, insulin efsitora alfa, tirzepatide, retatrutide, eloralintide ...
Eli Lilly and Company has announced that the data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at the American Diabetes Association's (ADA) 85th …